Monocyte Chemoattractant Protein-1 (MCP-1), Secreted by Bone Marrow Endothelial Cells, Induces Chemoattraction of 5T Multiple Myeloma Cells

Overview

Journal Clin Exp Metastasis

Specialty Oncology

Date 2002 Mar 29

PMID 11918087

Citations 20

Authors

Karin Vanderkerken

Isabelle Vande Broek

Decio L Eizirik

Els Van Valckenborgh

Kewal Asosingh

Ivan Van Riet

Ben Van Camp

Affiliations

Soon will be listed here.

Abstract

Homing of multiple myeloma (MM) cells to the bone marrow (BM) requires transendothelial migration. In the present work we tested whether monocyte chemoattractant protein-1 (MCP-1) and CCR2, the high affinity receptor for MCP-1, are involved in this process. Murine 5T2 and 5T33MM cell lines were selected as source of MM cells and STR4, 10 and 12 of BM endothelial cells (BMEC). RT-PCR demonstrated transcripts for MCP-1 in BMEC and ELISA the presence of MCP-1 protein in culture medium. RNase protection assay showed mRNA expression for CCR2, and FACS analysis the presence of CCR2 protein on the MM cells. EC conditioned medium induced chemoattraction of MM cells, a phenomenon inhibited by anti-MCP-1 antibodies. In conclusion, MM cells express CCR2 and are attracted by MCP-1 secreted by BMEC. We suggest that local MCP-1 production by BMEC is one of the mechanisms involved in homing of myeloma cells to the BM.

Citing Articles

Tumour Dissemination in Multiple Myeloma Disease Progression and Relapse: A Potential Therapeutic Target in High-Risk Myeloma.

Zeissig M, Zannettino A, Vandyke K Cancers (Basel). 2020; 12(12).

PMID: 33291672 PMC: 7761917. DOI: 10.3390/cancers12123643.

Tissue Factor-Expressing Tumor-Derived Extracellular Vesicles Activate Quiescent Endothelial Cells Protease-Activated Receptor-1.

Che S, Park J, Stokol T Front Oncol. 2017; 7:261.

PMID: 29164060 PMC: 5673848. DOI: 10.3389/fonc.2017.00261.

Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys.

Dudal S, Subramanian K, Flandre T, Law W, Lowe P, Skerjanec A MAbs. 2015; 7(5):829-37.

PMID: 26230385 PMC: 4622749. DOI: 10.1080/19420862.2015.1060384.

Smac Mimetic-Induced Upregulation of CCL2/MCP-1 Triggers Migration and Invasion of Glioblastoma Cells and Influences the Tumor Microenvironment in a Paracrine Manner.

Lindemann C, Marschall V, Weigert A, Klingebiel T, Fulda S Neoplasia. 2015; 17(6):481-9.

PMID: 26152356 PMC: 4719005. DOI: 10.1016/j.neo.2015.05.002.

Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma.

Tassone P, Neri P, Burger R, Di Martino M, Leone E, Amodio N Curr Cancer Drug Targets. 2012; 12(7):814-22.

PMID: 22671927 PMC: 3587184. DOI: 10.2174/156800912802429292.

References

Mohle R, Moore M, Nachman R, Rafii S . Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line. Blood. 1997; 89(1):72-80. View

Chen M, Schuit F, Eizirik D . Identification of IL-1beta-induced messenger RNAs in rat pancreatic beta cells by differential display of messenger RNA. Diabetologia. 1999; 42(10):1199-203. DOI: 10.1007/s001250051292. View

Frade J, Mellado M, del Real G, Gutierrez-Ramos J, Lind P, Martinez-A C . Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. J Immunol. 1998; 159(11):5576-84. View

Asosingh K, Radl J, Van Riet I, Van Camp B, Vanderkerken K . The 5TMM series: a useful in vivo mouse model of human multiple myeloma. Hematol J. 2002; 1(5):351-6. DOI: 10.1038/sj.thj.6200052. View

Leonard E, Yoshimura T . Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today. 1990; 11(3):97-101. DOI: 10.1016/0167-5699(90)90035-8. View

Butcher E, Picker L . Lymphocyte homing and homeostasis. Science. 1996; 272(5258):60-6. DOI: 10.1126/science.272.5258.60. View

Sica A, Wang J, Colotta F, Dejana E, Mantovani A, Oppenheim J . Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol. 1990; 144(8):3034-8. View

Vanderkerken K, Asosingh K, Braet F, Van Riet I, Van Camp B . Insulin-like growth factor-1 acts as a chemoattractant factor for 5T2 multiple myeloma cells. Blood. 1998; 93(1):235-41. View

Vanderkerken K, De Raeve H, Goes E, Van Meirvenne S, Radl J, Van Riet I . Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse. Br J Cancer. 1997; 76(4):451-60. PMC: 2227997. DOI: 10.1038/bjc.1997.409. View

10.

Vanderkerken K, de Greef C, Asosingh K, Arteta B, De Veerman M, Vande Broek I . Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse. Br J Cancer. 2000; 82(4):953-9. PMC: 2374415. DOI: 10.1054/bjoc.1999.1024. View

11.

Radl J, De Glopper E, SCHUIT H, Zurcher C . Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice. J Immunol. 1979; 122(2):609-13. View

12.

Imai K, Kobayashi M, Wang J, Ohiro Y, Hamada J, Cho Y . Selective transendothelial migration of hematopoietic progenitor cells: a role in homing of progenitor cells. Blood. 1998; 93(1):149-56. View

13.

Bakkus M, Heirman C, Van Riet I, Van Camp B, Thielemans K . Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood. 1992; 80(9):2326-35. View